daunorubicin has been researched along with valinomycin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
Bolard, J; Henry, N | 1 |
Bolhuis, H; Driessen, AJ; Konings, WN; Molenaar, D; Poelarends, G; Poolman, B; van Veen, HW | 1 |
Futai, M; Manabe, T; Moriyama, Y; Tashiro, Y; Yoshimori, T | 1 |
Damjanovich, S; Gaspar, R; Goda, K; Krasznai, Z; Lankelma, J; Szabó, G; Westerhoff, HV | 1 |
de Vries, EG; Garnier-Suillerot, A; Moretti, JL; Vergote, J | 1 |
7 other study(ies) available for daunorubicin and valinomycin
Article | Year |
---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport, Active; Biomarkers; Cells, Cultured; Drug Interactions; Fluorescent Dyes; Humans | 2003 |
Synergistic incorporation of daunorubicin in erythrocytes in the presence of polyene antibiotics. Role of the membrane potential.
Topics: Amphotericin B; Antifungal Agents; Azides; Buffers; Candicidin; Cations; Cell Membrane Permeability; Daunorubicin; Drug Synergism; Erythrocyte Membrane; Humans; Membrane Potentials; Potassium; Sodium Azide; Valinomycin | 1986 |
Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis.
Topics: Adenosine Triphosphate; Biological Transport; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethidium; Lactococcus lactis; Membrane Potentials; Mutation; Nigericin; Protons; Valinomycin; Vancomycin | 1994 |
ATP-dependent uptake of anti-neoplastic agents by acidic organelles.
Topics: Adenosine Triphosphate; Ammonium Chloride; Animals; Antineoplastic Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cattle; Cells, Cultured; Chromaffin Granules; Daunorubicin; Drug Resistance; Hydrogen-Ion Concentration; Mice; Nigericin; Organelles; Proteolipids; Proton-Translocating ATPases; Quinidine; Reserpine; Valinomycin; Vanadates; Verapamil | 1994 |
Reversal of multidrug resistance by valinomycin is overcome by CCCP.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Coloring Agents; Daunorubicin; Drug Resistance, Multiple; Humans; Ionophores; KB Cells; Kinetics; Potassium; Rhodamine 123; Rhodamines; Valinomycin; Vinblastine | 1996 |
Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Daunorubicin; Drug Resistance, Multiple; Humans; Kinetics; Membrane Potentials; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organotechnetium Compounds; Phenotype; Radiopharmaceuticals; Tumor Cells, Cultured; Valinomycin | 1998 |